Canada is a huge country geographically, yet a small one in terms of population. Our research community benefits from being part of national and international collaborations where they can both learn and contribute. Further, what we support under the genomics umbrella is broad – it is not just genome sequencing. We support a full suite of “-omics” technologies (for example, proteomics, metabolomics and epigenomics) as well as disciplines such as bioinformatics and computational biology, which seek to derive full value from the “big data” generated from genomics research. Our teams also feature experts from the social sciences and humanities who examine the societal dimensions of this disruptive technology to ensure risk is reduced and benefits maximized for Canadians. In this field, no one individual can do it alone. Multidisciplinary teams are critical for success. Last but not least, we foster a partnership of sorts through the makeup of our programs portfolio – that of science and innovation. The key to a successful enterprise is to work on both fuelling the pipeline for innovation through investment in fundamental research and technol- ogy platforms, while at the same time priming the receptor capacity for applications, including commercialization opportunities for Canadian business. In short, partnerships are the glue that hold together the strong collaborative network that is Canada’s genom- ics enterprise. And the quality and quantity of partnerships is what will underpin our ongoing success. Marc LePage President and chief executive officer Innovation is at the heart of all we do at Genome Canada. PARTNERING FOR SUCCESS 3 “Genome Canada is more than a federal program. It is truly a national program. Everyone is in.” — Marc LePage, president and chief executive officer Genome Canada Annual Report 2016-17